<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01675375</url>
  </required_header>
  <id_info>
    <org_study_id>CS 004</org_study_id>
    <nct_id>NCT01675375</nct_id>
  </id_info>
  <brief_title>Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain</brief_title>
  <official_title>Laser Vision Correction Use of an Eye Shield for Maintaining Vision and Mitigating Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FORSIGHT Vision3</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FORSIGHT Vision3</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to determine if an investigational thin shield can
      effectively reduce discomfort following Laser Vision Correction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of maintaining vision and mitigating pain post Laser Vision Correction using an Eye Shield</measure>
    <time_frame>1yr</time_frame>
    <description>Evidence of maintaining vision and mitigating pain post Laser Vision Correction using an Eye Shield by subjective patient questionnaires and objective imaging and slit lamp examination.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Post Laser Vision Correction Pain and Discomfort</condition>
  <arm_group>
    <arm_group_label>Eye shield</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eye shield place on post Laser Vision Correction eye</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eye Shield</intervention_name>
    <description>one application following refractive surgery</description>
    <arm_group_label>Eye shield</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo Laser Vision Correction for correction of refractive
             error

          -  FDA approved treatment guidelines for Laser Vision Correction

          -  Age 18-60

          -  Patients able to understand the requirements of the study, willing to follow study
             instructions, provide written informed consent to participate, and comply with all
             study requirements, including the required study follow-up visits

        Exclusion Criteria:

          -  Any other anterior segment abnormality other than that associated with LAser Vision
             Correction

          -  Any abnormalities associated with the eye lids

          -  Uncontrolled blepharitis or dry eye

          -  Prior laser treatment of the retina

          -  Any ophthalmic surgery performed within three (3) months prior to study excluding PRK
             or LASIK

          -  Diagnosis of glaucoma

          -  Active diabetic retinopathy

          -  Clinically significant inflammation or infection within six (6) months prior to study

          -  Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of
             the Investigator

          -  Participation in any study involving an investigational drug within the past 30
             calendar days, or ongoing participation in a study with an investigational material

          -  Intolerance or hypersensitivity to topical anesthetics, antibiotics, steroids or any
             other pharmaceuticals that may be used pre and post surgically

          -  Specifically known intolerance or hypersensitivity to contact lenses or any component
             of the investigative material

          -  A medical condition, serious concurrent illness, or extenuating circumstance that
             would significantly decrease study compliance, including all prescribed follow-up

          -  Any condition that, in the opinion of the investigator, would jeopardize the safety of
             the patient

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ClearView Eye and Laser</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kraff Eye Institute</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Talamo Laser Eye Consultants</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02451</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Physicians Protocol</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vance Thompson Vision</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2012</study_first_submitted>
  <study_first_submitted_qc>August 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2012</study_first_posted>
  <last_update_submitted>February 1, 2013</last_update_submitted>
  <last_update_submitted_qc>February 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

